Literature DB >> 7136430

Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.

R Heuman, R Sjödahl, C Tagesson.   

Abstract

We have investigated the intestinal permeability to polyethyleneglycol (PEG) 1 000 in 25 healthy individuals and 28 patients with Crohn's disease who had undergone ileocolic resection. The intestinal permeability was determined by measuring the 6-hour urinary recovery after oral intake of 10 g PEG 1 000. The patients with Crohn's disease excreted significantly less (p less than 0.001) PEG 1 000 than the healthy individuals (33.7 +/- 16.0 per thousand of the ingested dose vs. 48.6 +/- 15.5 per thousand). There was a correlation between the urinary output and the length of ileal resection, but no difference in output between patients with and without recurrent disease or episodic arthralgia. These findings indicate that, although the gut is considerably permeable to larger, polar molecules, and permeability to PEG 1 000 in Crohn's disease is not increased over that in healthy individuals and appears unrelated to the presence of recurrence and arthralgia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7136430

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  5 in total

1.  PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers.

Authors:  D Ruttenberg; G O Young; J P Wright; S Isaacs
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

Review 2.  New pathophysiological insights and modern treatment of IBD.

Authors:  Matthias A Engel; Markus F Neurath
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

3.  Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.

Authors:  G Olaison; P Leandersson; R Sjödahl; C Tagesson
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

4.  Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease.

Authors:  L Pironi; M Miglioli; E Ruggeri; M Levorato; M A Dallasta; C Corbelli; M G Nibali; L Barbara
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

5.  Effect of N-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability. A model of local inflammatory process.

Authors:  K E Magnusson; C Dahlgren; A Sjölander
Journal:  Inflammation       Date:  1985-12       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.